Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial
<p>Cerebral hypoxia may promote cerebral damage in patients with obstructive sleep apnoea (OSA). We investigated whether OSA patients experience nocturnal cerebral hypoxia that is prevented by continuous positive airway pressure (CPAP).</p> <p>OSA patients using CPAP underwent slee...
主要な著者: | Schwarz, E, Furian, M, Schlatzer, C, Stradling, J, Kohler, M, Bloch, K |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
European Respiratory Society
2018
|
類似資料
-
ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial.
著者:: Schlatzer, C, 等
出版事項: (2016) -
Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: A systematic review and meta-analysis.
著者:: Schwarz, E, 等
出版事項: (2015) -
Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: A systematic review and meta-analysis
著者:: Schwarz, E, 等
出版事項: (2015) -
Pharmacological approaches to the treatment of obstructive sleep apnoea.
著者:: Kohler, M, 等
出版事項: (2009) -
The role of the nose in the pathogenesis of obstructive sleep apnoea and snoring.
著者:: Kohler, M, 等
出版事項: (2007)